{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:15:19Z","timestamp":1786421719626,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273785"],"award-info":[{"award-number":["82273785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioorg.2026.109481","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:09:09Z","timestamp":1767802149000},"page":"109481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of 1-(4-cyanopyrimidin-2-yl)-1H-pyrazole-4-carboxylic acids as potent xanthine oxidase inhibitors via molecular cleavage and reassembly of allopurinol as a key strategy"],"prefix":"10.1016","volume":"170","author":[{"given":"Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10287","key":"10.1016\/j.bioorg.2026.109481_bb0005","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Gout, The Lancet"},{"key":"10.1016\/j.bioorg.2026.109481_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101882","article-title":"Xanthine oxidoreductase: one enzyme for multiple physiological tasks","volume":"41","author":"Bortolotti","year":"2021","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.109481_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000512178","article-title":"Clinical effects of xanthine oxidase inhibitors in Hyperuricemic patients","volume":"30","author":"Cicero","year":"2021","journal-title":"Med. Princ. Pract."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109481_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/molecules28041921","article-title":"Xanthine oxidase\u2014a personal history","volume":"28","author":"Hille","year":"2023","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.bioorg.2026.109481_bb0025","doi-asserted-by":"crossref","first-page":"14474","DOI":"10.1021\/acs.jmedchem.3c01710","article-title":"Agents for the treatment of gout: current advances and future perspectives","volume":"66","author":"Zeng","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109481_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jjcc.2020.12.013","article-title":"Uric acid and cardiovascular disease: a clinical review","volume":"78","author":"Saito","year":"2021","journal-title":"J. Cardiol."},{"issue":"22","key":"10.1016\/j.bioorg.2026.109481_bb0035","doi-asserted-by":"crossref","first-page":"19966","DOI":"10.1021\/acs.jmedchem.4c01260","article-title":"Recent Progress and future perspectives on anti-Hyperuricemic agents","volume":"67","author":"Sun","year":"2024","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.109481_bb0040","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.bioorg.2026.109481_bb0045","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/1381612827666210104124320","article-title":"Serum uric acid and diabetes: from pathophysiology to cardiovascular disease","volume":"27","author":"Katsiki","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2026.109481_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112077","article-title":"Design, synthesis and biological evaluation of 1-Alkyl-5\/6-(5-Oxo-4,5-Dihydro-1,2,4-Oxadiazol-3-yl)-1H-Indole-3-carbonitriles as novel xanthine oxidase inhibitors","volume":"190","author":"Gao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109481_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2015.08.056","article-title":"Synthesis and evaluation of 1-hydroxy\/Methoxy-4-Methyl-2-phenyl-1H-Imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors","volume":"103","author":"Chen","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109481_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113928","article-title":"Design, synthesis, and biological evaluation of N-(3-Cyano-1H-Indol-5\/6-yl)-6-Oxo-1,6-Dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-Dihydropyrimidin-2-yl)-1H-Indole-3-carbonitriles as novel xanthine oxidase inhibitors","volume":"227","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109481_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116443","article-title":"Design, synthesis, and biological evaluation of 5-(1H-Indol-5-yl)Isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors","volume":"271","author":"Huang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109481_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116407","article-title":"Design, synthesis, and biological evaluation of 3-phenyl substituted pyridine derivatives as potential dual inhibitors of XOR and URAT1","volume":"271","author":"Yang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2026.109481_bb0075","doi-asserted-by":"crossref","first-page":"14668","DOI":"10.1021\/acs.jmedchem.4c01480","article-title":"Discovery of a potent and orally bioavailable xanthine oxidase\/urate transporter 1 dual inhibitor as a potential treatment for hyperuricemia and gout","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"40","key":"10.1016\/j.bioorg.2026.109481_bb0080","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.2174\/0929867325666180904125400","article-title":"Pyridine and pyrimidine derivatives as privileged scaffolds in biologically active agents","volume":"26","author":"Chiacchio","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109481_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph17010104","article-title":"Recent advances in pyrimidine-based drugs","volume":"17","author":"Nammalwar","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109481_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114946","article-title":"Pyrimidine derivatives with antitubercular activity","volume":"246","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109481_bb0095","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2174\/1389557521666211008153329","article-title":"An overview of the synthetic route to the marketed formulations of pyrimidine: a review","volume":"22","author":"Kumar","year":"2022","journal-title":"Mini-Reviews in Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109481_bb0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejmech.2016.04.077","article-title":"The therapeutic voyage of pyrazole and its Analogs: a review","volume":"120","author":"Khan","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109481_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23010134","article-title":"Synthesis and pharmacological activities of pyrazole derivatives: a review","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bioorg.2026.109481_bb0110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/1570179418666210301122322","article-title":"Synthesis and functionalization of coumarin-pyrazole scaffold: recent development, challenges, and opportunities","volume":"18","author":"Jadhav","year":"2021","journal-title":"Curr. Org. Synth."},{"key":"10.1016\/j.bioorg.2026.109481_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2013.08.053","article-title":"Pyrazole containing natural products: synthetic preview and biological significance","volume":"69","author":"Kumar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109481_bb0120","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/1389557516666151120115302","article-title":"Therapeutic outlook of pyrazole Analogs: a Mini review","volume":"17","author":"Ganguly","year":"2017","journal-title":"Mini-Rev. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2026.109481_bb0125","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1016\/j.bmc.2017.09.035","article-title":"Recently reported biological activities of pyrazole compounds","volume":"25","author":"Faria","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109481_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27248708","article-title":"Recent advancement in drug design and discovery of pyrazole biomolecules as Cancer and inflammation therapeutics","volume":"27","author":"Alam","year":"2022","journal-title":"Molecules"},{"issue":"22","key":"10.1016\/j.bioorg.2026.109481_bb0135","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2174\/1568026623666230714161726","article-title":"Pyrazole; a privileged scaffold of medicinal chemistry: a comprehensive review","volume":"23","author":"Kumar","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109481_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms24097834","article-title":"Amino-pyrazoles in medicinal chemistry: a review","volume":"24","author":"Lusardi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109481_bb0145","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1074\/jbc.M208307200","article-title":"An extremely potent inhibitor of xanthine oxidoreductase: crystal structure of the enzyme-inhibitor of complex and mechanism of inhibition","volume":"278","author":"Okamoto","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109481_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.07.062","article-title":"Targeting the subpocket in xanthine oxidase: design, synthesis, and biological evaluation of 2-[4-Alkoxy-3-(1H-Tetrazol-1-yl) phenyl]-6-Oxo-1,6-Dihydropyrimidine-5-carboxylic acid derivatives","volume":"181","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.109481_bb0155","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1021\/acs.jmedchem.0c00223","article-title":"Novel human urate transporter 1 inhibitors as hypouricemic drug candidates with Favorable Druggability","volume":"63","author":"Zhao","year":"2020","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2026.109481_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313121","article-title":"Overcoming challenges in small-molecule drug bioavailability: a review of key factors and approaches","volume":"25","author":"Wu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109481_bb0165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug\u2013target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109481_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111664","article-title":"Accurate quantitative determination of affinity and binding kinetics for tight binding inhibition of xanthine oxidase","volume":"139","author":"Yang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"26","key":"10.1016\/j.bioorg.2026.109481_bb0175","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1039\/C5CC00111K","article-title":"Synthesis of orotidine by intramolecular Nucleosidation","volume":"51","author":"Kim","year":"2015","journal-title":"Chem. Commun."},{"issue":"43","key":"10.1016\/j.bioorg.2026.109481_bb0180","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1002\/anie.200904188","article-title":"Mapping the landscape of potentially primordial informational oligomers: oligo-dipeptides tagged with Orotic acid derivatives as recognition elements","volume":"48","author":"Zhang","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109481_bb0185","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1021\/jo2003715","article-title":"Solvent-free or low-solvent large-scale preparation of Chloropyrimidine and analogues","volume":"76","author":"Sun","year":"2011","journal-title":"J. Organomet. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109481_bb0190","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.bmc.2015.05.059","article-title":"Discovery of a novel class anti-proliferative agents and potential inhibitors of EGFR tyrosine kinases based on 4-Anilinotetrahydropyrido[4,3-d]pyrimidine scaffold: design, synthesis and biological evaluations","volume":"23","author":"Zhang","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109481_bb0195","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bmcl.2015.03.046","article-title":"Discovery of new Acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a Pyrrolopyridinone Core","volume":"25","author":"Sivaprakasam","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.bioorg.2026.109481_bb0200","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1021\/jm300965a","article-title":"Structural sweet spot for A1 adenosine receptor activation by truncated (N)-Methanocarba nucleosides: receptor docking and potent anticonvulsant activity","volume":"55","author":"Tosh","year":"2012","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109481_bb0205","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/ml400186z","article-title":"Potent and orally bioavailable GPR142 agonists as novel insulin secretagogues for the treatment of type 2 diabetes","volume":"4","author":"Toda","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109481_bb0210","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jfluchem.2011.07.014","article-title":"Catalyst-free one-pot synthesis of 1,4,5-trisubstituted pyrazoles in 2,2,2-trifluoroethanol","volume":"132","author":"Alinezhad","year":"2011","journal-title":"J. Fluor. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2026.109481_bb0215","doi-asserted-by":"crossref","first-page":"10136","DOI":"10.1021\/jm301252n","article-title":"Novel acidic 11\u03b2-hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-Adamantylcarbamoyl)-5-Tert-butyl-Pyrazol-1-yl]benzoic acid (AZD8329)","volume":"55","author":"Scott","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109481_bb0220","series-title":"Antidepressant heteroaryl derivatives of heterocycle-fused benzodioxans","author":"Failli","year":"2008"},{"issue":"14","key":"10.1016\/j.bioorg.2026.109481_bb0225","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1074\/jbc.270.14.7816","article-title":"Mechanism of inhibition of xanthine oxidase with a new tight binding inhibitor","volume":"270","author":"Okamoto","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.109481_bb0230","series-title":"GraphPad Prism for Windows, Version 6.0","year":"2014"},{"key":"10.1016\/j.bioorg.2026.109481_bb0235","unstructured":"Schr\u00f6dinger, LLC: New York 2023."},{"key":"10.1016\/j.bioorg.2026.109481_bb0240","unstructured":"The PyMOL Molecular Graphics System, version 1.7.2.1 2006."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.109481_bb0245","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:14:24Z","timestamp":1770066864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"alternative-id":["S0045206826000179"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109481","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 1-(4-cyanopyrimidin-2-yl)-1H-pyrazole-4-carboxylic acids as potent xanthine oxidase inhibitors via molecular cleavage and reassembly of allopurinol as a key strategy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109481"}}